Suk‐Joon Chang

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon et al. · Journal of Clinical Oncology · 2023 · 331 citations · Full text

Medicine, Oncology, Pharmacology +12

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease

Michelle Wilson, Éric Pujade-Lauraine, Daisuke Aoki et al. · Annals of Oncology · 2016 · 296 citations · Full text

Medicine, Gynecology, Oncology +16

Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer

Myong Cheol Lim, Suk‐Joon Chang, Boram Park et al. · JAMA Surgery · 2022 · 214 citations · Full text

Medicine, Oncology, Surgery +17

Clinical characteristics of struma ovarii

Seung‐Chul Yoo, Ki‐Hong Chang, Mi-Ok Lyu et al. · Journal of Gynecologic Oncology · 2008 · 212 citations · Full text

Medicine, Gynecology, Surgery +13

Impact of Complete Cytoreduction Leaving No Gross Residual Disease Associated with Radical Cytoreductive Surgical Procedures on Survival in Advanced Ovarian Cancer

Suk‐Joon Chang, Robert E. Bristow, Hee‐Sug Ryu · Annals of Surgical Oncology · 2012 · 209 citations

Medicine, Gynecology, Surgery +14